The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
IL-17 Immunity in Human Type 1 Diabetes
Abstract
Th17 immunity has been shown to regulate autoimmune diabetes in mice. IL-17 neutralization prevented development of diabetes when given postinitiation of insulitis but not earlier, suggesting interference with the effector phase of the disease. Islet-cell Ag-specific Th17 cells converted into IFN-γ–secreting Th1-like cells and caused diabetes in mice recipients. The role of IL-17 in human type 1 diabetes (T1D) is, however, not established. In this study, we show upregulation of Th17 immunity in peripheral blood T cells from children with T1D. This was characterized by increased IL-17 secretion and expression of IL-17, IL-22, and retinoic acid-related orphan receptor C isoform 2, but also FOXP3 transcripts upon T cell activation in vitro. Also, circulating memory CD4 cells from children with T1D showed the same pattern of IL-17, IL-22 and FOXP3 mRNA upregulation, indicating IL-17 pathway activation in vivo. IL-17–positive T cells appeared to be CD4+ cells expressing TCR-αβ and CCR6, and a subpopulation showed coproduction of IFN-γ. Given the Th17 immunity in T1D, we demonstrated that IL-17 had detrimental effects on human islet cells in vitro; it potentiated both inflammatory and proapoptotic responses. Our findings highlight the role of IL-17 immunity in the pathogenesis of human T1D and point to a potential therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1774 · Cited by 1,370
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Late Developmental Plasticity in the T Helper 17 Lineage
Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.005 · Cited by 1,053
Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636435 · Cited by 1,011
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 927
Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1999 · Cited by 842
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809 · cited 1×
“modulating the thymic insulin expression confer susceptibility to T1D (40, 41).”
BackgroundHuman CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., & Joosten, I. (2008) · Blood · doi:10.1182/blood-2008-01-133967 · Cited by 736
Identification of IL-17-producing FOXP3+regulatory T cells in humans
Voo, K. S., Wang, Y.-H., Santori, F. R., Boggiano, C., Wang, Y.-H., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900408106 · Cited by 689
Bending, D., De La Peña, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B., & Cooke, A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37865 · Cited by 558
CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin-Orozco, N., Kang, H. S., Ma, L., Panopoulos, A. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8391 · Cited by 551
Sapone, A., de Magistris, L., Pietzak, M., Clemente, M. G., Tripathi, A., Cucca, F., Lampis, R., Kryszak, D., Cartenì, M., Generoso, M., et al. (2006) · Diabetes · doi:10.2337/db05-1593 · Cited by 543
Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H., & Hori, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811556106 · Cited by 523
Increased intestinal permeability precedes clinical onset of type 1 diabetes
Bosi, E., Molteni, L., Radaelli, M. G., Folini, L., Fermo, I., Bazzigaluppi, E., Piemonti, L., Pastore, M. R., & Paroni, R. (2006) · Diabetologia · doi:10.1007/s00125-006-0465-3 · Cited by 443
Developmental plasticity of Th17 and Treg cells
Lee, Y. K., Mukasa, R., Hatton, R. D., & Weaver, C. T. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.021 · Cited by 423
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
Emamaullee, J. A., Davis, J., Merani, S., Toso, C., Elliott, J. F., Thiesen, A., & Shapiro, A. M. J. (2009) · Diabetes · doi:10.2337/db08-1113 · Cited by 378
Martin‐Orozco, N., Chung, Y., Chang, S. H., Wang, Y., & Dong, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200838475 · Cited by 359
Bradshaw, E. M., Raddassi, K., Elyaman, W., Orban, T., Gottlieb, P. A., Kent, S. C., & Hafler, D. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900576 · Cited by 297
Ylipaasto, P., Klingel, K., Lindberg, A. M., Otonkoski, T., Kandolf, R., Hovi, T., & Roivainen, M. (2004) · Diabetologia · doi:10.1007/s00125-003-1297-z · Cited by 295
Self-citationAyyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., & Valmori, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900621106 · Cited by 293
Cardozo, A. K., Kruhøffer, M., Leeman, R., Ørntoft, T., & Eizirik, D. L. (2001) · Diabetes · doi:10.2337/diabetes.50.5.909 · Cited by 229
IL-23/IL-17 immunity as a hallmark of Crohnʼs disease
Hölttä, V., Klemetti, P., Sipponen, T., Westerholm-Ormio, M., Kociubinski, G., Salo, H., Räsänen, L., Kolho, K.-L., Färkkilä, M., Savilahti, E., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20475 · Cited by 196
Self-citationJain, R., Tartar, D. M., Gregg, R. K., Divekar, R. D., Bell, J. J., Lee, H.-H., Yu, P., Ellis, J. S., Hoeman, C. M., Franklin, C. L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071878 · Cited by 180
Marks, B. R., Nowyhed, H. N., Choi, J.-Y., Poholek, A. C., Odegard, J. M., Flavell, R. A., & Craft, J. (2009) · Nature Immunology · doi:10.1038/ni.1783 · Cited by 173
Immunologic Activity in the Small Intestinal Mucosa of Pediatric Patients With Type 1 Diabetes
Westerholm-Ormio, M., Vaarala, O., Pihkala, P., Ilonen, J., & Savilahti, E. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2287 · Cited by 170
Self-citationJohansson, U., Olsson, A., Gabrielsson, S., Nilsson, B., & Korsgren, O. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01392-5 · Cited by 166
Regulation of IL-17 in Human CCR6+ Effector Memory T Cells
Liu, H., & Rohowsky‐Kochan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7948 · Cited by 133
Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis.
Robertson, R. P. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1379 · Cited by 117
Yang, X., Sytwu, H., McDevitt, H. O., & Michie, S. A. (1997) · Diabetes · doi:10.2337/diacare.46.10.1542 · Cited by 114
Sarkar, S. A., Kutlu, B., Velmurugan, K., Kizaka‐Kondoh, S., Lee, C. E., Wong, R., Valentine, A., Davidson, H. W., Hutton, J. C., & Pugazhenthi, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1331-x · Cited by 98
Hänninen, A. L. M., Salmi, M., Simell, O., & Jalkanen, S. (1996) · Diabetes · doi:10.2337/diab.45.9.1173 · Cited by 94
In Vitro–Deranged Intestinal Immune Response to Gliadin in Type 1 Diabetes
Auricchio, R., Paparo, F., Maglio, M. A., Franzese, A., Lombardi, F., Valerio, G., Nardone, G., Percopo, S., Greco, L., & Troncone, R. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1680 · Cited by 90
Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells
Miljković, D. M., Cvetković, I., Momčilović, M. B., Maksimović‐Ivanić, D., Stošić‐Grujičić, S., & Trajković, V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5259-0 · Cited by 65
Hänninen, A. L. M., Salmi, M., Simell, O., & Jalkanen, S. (1993) · Diabetes · doi:10.2337/diab.42.11.1656 · Cited by 56
Boehm, B. O., Rosinger, S., Sauer, G., Manfras, B. J., Palesch, D., Schiekofer, S., Kalbacher, H., & Burster, T. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.007 · Cited by 18
Cited by
IL-17 and IL-17-producing cells in protection versus pathology
Mills, K. H. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00746-9 · Cited by 1,000
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
Risk Factors for the Development of Psoriasis
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184347 · Cited by 640
Kaymaz, K., & Beikler, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143394 · Cited by 534
The IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
Metadata
- Authors
- Honkanen, J., Nieminen, J. K., Gao, R., Luopajarvi, K., Salo, H. M., Ilonen, J., Knip, M., Otonkoski, T., & Vaarala, O.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08-01
- Volume
- 185
- Issue
- 3
- Pages
- 1959-1967
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2135201054
- Cited by
- 297
- References
- 41
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.